Stocks
G1 Therapeutics (GTHX) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -5.26 | -2.04 | -1.30 | -1.30 | -3.87 | -10.8 | ||
| Changes by years, y/y, % | -61% | -36% | 0% | +197% | +5.2% | ||||
G1 Therapeutics. EV/EBITDA
G1 Therapeutics. EV/EBITDA, changes, %
G1 Therapeutics (GTHX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EV/EBITDA | ? | -1.28 | 0.27 | -3.88 | -11.5 | -3.19 | -10.8 | |
| Changes by years, y/y, % | +39% | -108% | +175% | +4 611% | +149% | |||
| Changes by quarters, q/q, % | +426% | -121% | -1 553% | +196% | -72% | |||
